(5-Bromo-3-methylpyridin-2-yl)methanol, 97%, 250mg

(1H-Pyrrol-2-yl)methanamine hydrochloride, 95.0%, 250mg

1-(7-Fluoroquinolin-6-yl)ethanone, 98%, 100mg

4-(4-Fluorophenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine, 250mg

3,5-Dichloro-4-fluoropyridine, 95.0%, 5g

ETHYL (R)-1-BOC-4-OXOPIPERIDINE-2-CARBOXYLATE, 95.0%, 500mg

2-oxocyclohexane-1-sulfonamide, 95.0%, 250mg

Fmoc-L-Lysine-(Boc), PEPTIPURE®, min. 98.5%, for biochemistry, 100 g, glass packaging

(3E)-2-{4-[(TERT-BUTYL)OXYCARBONYL]PIPERAZINYL}-4-PHENYLBUT-3-ENOIC ACID, 95.0%, 250mg

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide>95.0%(GC)25g

6-Chloropyrrolo[2,1-f][1,2,4]triazin-4(1H)-one, 98+%, 100mg

2-Chloro-N-(2-{5-[(2-chlorophenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl}ethyl)acetamide, 97%, 250mg

2-Isopropoxy-4,4,6-trimethyl-1,3,2-dioxaborinane, 95+%, 100mg